Fatty Liver Disease And Tylenol
Fatty liver disease, or NASH, which stands for non-alcoholic hepatic steatosis, is a detrimental body condition influenced by the accumulation of excessive fat deposits in the liver. This condition is a disease that sometimes occurs due to overindulgence and excessive usage of analgesics like acetaminophen-containing brands like Tylenol.
The augmentative effects of acetaminophen in the metabolic syndrome of the accumulation of fatty deposits in the liver have been established by clinical studies.
Fatty deposit accumulation in the liver can happen due to various reasons of which metabolic disorders are the main concern. A mis-performing metabolic system can even lead to obesity, which can, in turn, lead to accumulation of excessive fat deposits in the liver thus compromising its health and function. The liver can get excessively damaged due to resulting cirrhosis after the over accumulation of fatty deposits in it. Conventional methods like liver transplants are the only opportunities available for recuperation from this condition, while simplistic diet modifications and alternative medicinal therapies are found to be mostly ineffective.
Tylenol or acetaminophen is entirely metabolized by the liver and hence, the concern for damage caused by overuse of this drug is high. The condition of fatty liver disease is augmented by the overuse of Tylenol rather than the standard dosage under prescriptions.
Also, eating a high fat diet leads to over accumulation of triglycerides and cholesterol in the liver, and thus increasing the chances of heart disease, heart attacks and arterial congestion. Overindulgence in Tylenol use can increase the metabolic disorder syndromes in the liver due to many established factors in clinical circles.
More Articles :